Multiple Sclerosis News & Features

People with MS who used cannabis-derived drugs reported slightly fewer muscle contractions, less bladder dysfunction and pain in a new study. But the self-reported results differed from those doctors came up with.

Older patients with MS have less depression and better quality of life compared with younger people, new research suggests.

The first drug approved for use in children with MS reduced relapse rates by 82 percent in people aged 10 to 17 compared with interferon beta-1a, a drug commonly used to slow the progression of the degenerative nerve disease.

Researchers have discovered a new subtype of multiple sclerosis, in which neurons die but there appears to be no damage to the myelin, the fatty, protective covering on nerve cells. The discovery changes the way scientists have understood the disease.

New MRI Test May Predict Severity of MS By Serena GordonHealthDay Reporter TUESDAY, July 17, 2018 (HealthDay News) -- People with multiple sclerosis (MS) often live with uncertainty because it's hard to predict how quickly the disease will progress and how disabling it might become.But researchers hope a new MRI test that tracks iron levels in the brain will help answer those questions. The test -- called quantitative susceptibility mapping (QSM) -- looks at different areas of the brain and how much iron is deposited in each. In some brain areas, a higher iron level is linked

Among those with a genetic predisposition and organic solvent exposure, MS risk rose sevenfold. About 60 percent of all the MS cases seen fell into this category.

The new guidelines, issued by the academy, took into account studies on MS drugs and concluded that it's best to start use of MS drugs as early as possible.

The treatment involves using cancer drugs to decimate a patient's immune system and then restarting it with a stem cell transplant, BBC News reported.

The current study included more than 1,100 people from Southern California. Their average age was 36. Half had been diagnosed with early MS or with clinically isolated syndrome.

Those who take Tysabri (natalizumab) to manage their MS are more likely to suffer a relapse during pregnancy if they stop taking the drug before they conceive, the first study found.

The new regimen -- called Balance and Eye-Movement Exercises for Persons with Multiple Sclerosis (BEEMS) -- had individuals perform balance and eye-movement exercises.

The study also found that a healthy lifestyle was linked to less depression, fatigue and pain for people with MS.

I have learned a lot about myself since being diagnosed with MS, and it turns out that I am not good at accepting help.

A wheelchair can help you do more, not less.

Get tips on how on how to be a caregiver for a friend or relative who has multiple sclerosis (MS).

My priority is finding the treatment that will keep me at my best, but fear of the unknown always creeps back in.

You may have heard drinking coffee can prevent MS. Separate the facts from the myth.

These regimens raised the risk for disease relapse, study found

Taking care of my mind, body, and spirit is just as important as keeping up with my medical care.

Latest study shows blacks and Hispanics also vulnerable

Benefits reported for women who nursed 15 months or more

Learning to Let Go of My Pre-MS Life At 25, I worked as a neurosurgical intensive care nurse and was a year into graduate school. In my spare time, I played the piano to ease stress and re-center myself. I seemed like a typical young, healthy, ambitious person. But I had been having -- and ignoring -- strange symptoms for quite some time.As a nurse, I saw neurological diseases every day, so I’m sure there was a part of me that recognized my symptoms. But after witnessing how devastating those diseases can be, I could not bring myself

I knew I had to make my health more of a priority so that I could keep doing the things I loved for as long as possible.

Study might explain why some multiple sclerosis patients stop understanding what others are feeling

First step was to test its safety in small trial of 6 people